ARCHIVES

R.S.K. Young Quits As FDA Oncology Group Leader

This article is from The Cancer Letter archive.

Vol. 06 No. 28 | July 11, 1980

Download PDF Visit The Full Archive

Related Articles

Shubik Subcommittee Criticizes New Study Section, Asks NCI To Hire More Epidemiologists

December 5, 1975

Trial Data: No Benefit In Adding Perifosine to Capecitabine

June 29, 2012

House Members Urge FDA to Review Fast Track Policies

July 5, 2002

AACR Presents 2014 Awards, Arteaga Becomes President at Annual Meeting

April 11, 2014

Bush Limits Drug Company Efforts To Block Generics

October 25, 2002

In Brief: Coltman, Leb Lead ASCO, AACR; Young, Busch Presidents Elect; Renalda Hilkemeyer Honored

June 3, 1988